Helmuth Haslacher

Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial

Rupert Bartsch, Anna S. Berghoff, Julia Furtner et al. · Nature Medicine · 2022 · 392 citations · Full text

Medicine, Oncology, Pharmacology +17

A Randomized Trial of Bortezomib in Late Antibody-Mediated Kidney Transplant Rejection

Farsad Eskandary, Heinz Regele, Lukas Baumann et al. · Journal of the American Society of Nephrology · 2017 · 297 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Mean Platelet Volume May Represent a Predictive Parameter for Overall Vascular Mortality and Ischemic Heart Disease

Georg Slavka, Thomas Perkmann, Helmuth Haslacher et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2011 · 259 citations · Full text

Medicine, Hematology, Internal Medicine +15

SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity

Daniel Mrak, Selma Tobudic, Maximilian Koblischke et al. · Annals of the Rheumatic Diseases · 2021 · 251 citations

Life Sciences, Immunology, Pharmacotherapy +17

Anti-Spike Protein Assays to Determine SARS-CoV-2 Antibody Levels: a Head-to-Head Comparison of Five Quantitative Assays

Thomas Perkmann, Nicole Perkmann‐Nagele, Thomas Köller et al. · Microbiology Spectrum · 2021 · 195 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16